Active Cancer Biomarkers Grants

PI Name Organization - Company Title Major Program / Research Group FOAsort descending
Carter, Bob S Massachusetts General Hospital Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Agarwal, Ashutosh University Of Miami School Of Medicine A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Papadopoulos, Nickolas Johns Hopkins University Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Wu, Yun State University Of New York At Buffalo Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Innovative Technology Development for Cancer Research RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Singamaneni, Srikanth Washington University METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION RFA-CA-18-004: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Faris, Gregory W Numentus Technologies Inc. Decoding Individual Exosomes in Cancer RFA-CA-20-017: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Nautiyal, Shivani Prime Genomics, Inc. Device for Preservation of Cell Free RNA in Saliva RFA-CA-20-019: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Hirsch, Fred R Icahn School Of Medicine At Mount Sinai Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Figueiredo, Jane C. Cedars-Sinai Medical Center Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Moormann, Ann M Univ Of Massachusetts Med Sch Worcester Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory) COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Fan, Rong Yale University Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies COVID Serology RFA-CA-20-039: Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences
Mantis, Nicholas J. Wadsworth Center High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology COVID Serology RFA-CA-20-039: Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences
Sariol, Carlos A University Of Puerto Rico Med Sciences SARS-CoV-2 correlates of protection in a Latino-origin population COVID Serology RFA-CA-20-039: Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences
Zarrinpar, Amir University Of California, San Diego Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer RFA-CA-20-054: Collaborative Approaches to Engineer Biology for Cancer Applications

Pages